Lecture: Managing diabetes in daily cardiovascular practice: Potential barriers and solutions
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- CDMC 2018: Shifting gears in the management of diabetes and CVDTwo choices of drugs that reduce CV risk in T2DM
Prof. John Deanfield, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDTranslating mechanisms of GLP-1RAs and SGLT2 inhibitors to CV benefits
Dr. Adie Viljoen, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDBenefits of GLP-1RA and SGLT2-i in primary and secondary prevention of CVD in T2DM
Prof. Eduard Montanya, MD
- CDMC 2018: Shifting gears in the management of diabetes and CVDLecture: Clinical trials in T2DM & CVD: Review of key outcomes with GLP-1 RA and SGLT2i
Prof. Eduard Montanya Barcelona
